Qilian International Holding Group (BGM) Competitors $10.72 -0.15 (-1.38%) Closing price 04:00 PM EasternExtended Trading$10.68 -0.04 (-0.37%) As of 04:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsSEC FilingsTrendsBuy This Stock BGM vs. PTCT, ZLAB, OGN, ACLX, RNA, RARE, RYTM, SWTX, AKRO, and CRNXShould you be buying Qilian International Holding Group stock or one of its competitors? The main competitors of Qilian International Holding Group include PTC Therapeutics (PTCT), Zai Lab (ZLAB), Organon & Co. (OGN), Arcellx (ACLX), Avidity Biosciences (RNA), Ultragenyx Pharmaceutical (RARE), Rhythm Pharmaceuticals (RYTM), SpringWorks Therapeutics (SWTX), Akero Therapeutics (AKRO), and Crinetics Pharmaceuticals (CRNX). These companies are all part of the "pharmaceutical products" industry. Qilian International Holding Group vs. PTC Therapeutics Zai Lab Organon & Co. Arcellx Avidity Biosciences Ultragenyx Pharmaceutical Rhythm Pharmaceuticals SpringWorks Therapeutics Akero Therapeutics Crinetics Pharmaceuticals Qilian International Holding Group (NASDAQ:BGM) and PTC Therapeutics (NASDAQ:PTCT) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, media sentiment, risk, valuation, dividends, community ranking, analyst recommendations, earnings and institutional ownership. Does the media favor BGM or PTCT? In the previous week, PTC Therapeutics had 12 more articles in the media than Qilian International Holding Group. MarketBeat recorded 12 mentions for PTC Therapeutics and 0 mentions for Qilian International Holding Group. PTC Therapeutics' average media sentiment score of 0.65 beat Qilian International Holding Group's score of 0.00 indicating that PTC Therapeutics is being referred to more favorably in the news media. Company Overall Sentiment Qilian International Holding Group Neutral PTC Therapeutics Positive Is BGM or PTCT more profitable? Qilian International Holding Group has a net margin of 0.00% compared to PTC Therapeutics' net margin of -50.32%. Company Net Margins Return on Equity Return on Assets Qilian International Holding GroupN/A N/A N/A PTC Therapeutics -50.32%N/A -16.44% Do analysts rate BGM or PTCT? PTC Therapeutics has a consensus price target of $63.77, suggesting a potential upside of 47.48%. Given PTC Therapeutics' stronger consensus rating and higher probable upside, analysts plainly believe PTC Therapeutics is more favorable than Qilian International Holding Group.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Qilian International Holding Group 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00PTC Therapeutics 2 Sell rating(s) 4 Hold rating(s) 8 Buy rating(s) 1 Strong Buy rating(s) 2.53 Which has more volatility and risk, BGM or PTCT? Qilian International Holding Group has a beta of 1.32, suggesting that its stock price is 32% more volatile than the S&P 500. Comparatively, PTC Therapeutics has a beta of 0.58, suggesting that its stock price is 42% less volatile than the S&P 500. Does the MarketBeat Community prefer BGM or PTCT? PTC Therapeutics received 569 more outperform votes than Qilian International Holding Group when rated by MarketBeat users. CompanyUnderperformOutperformQilian International Holding GroupN/AN/APTC TherapeuticsOutperform Votes56961.92% Underperform Votes35038.08% Which has better valuation & earnings, BGM or PTCT? Qilian International Holding Group has higher earnings, but lower revenue than PTC Therapeutics. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioQilian International Holding Group$25.10M41.53-$1.44MN/AN/APTC Therapeutics$806.78M4.23-$626.60M-$4.73-9.14 SummaryPTC Therapeutics beats Qilian International Holding Group on 8 of the 13 factors compared between the two stocks. Remove Ads Get Qilian International Holding Group News Delivered to You Automatically Sign up to receive the latest news and ratings for BGM and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BGM vs. The Competition Export to ExcelMetricQilian International Holding GroupPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.04B$6.32B$5.24B$7.07BDividend YieldN/A2.85%4.87%4.05%P/E RatioN/A6.7221.1817.48Price / Sales41.53186.91356.3585.27Price / CashN/A65.6738.1634.64Price / Book1.765.576.233.79Net Income-$1.44M$141.67M$3.20B$247.10M7 Day Performance-5.55%-11.44%-8.32%-7.32%1 Month Performance15.58%-14.59%-3.36%-10.19%1 Year PerformanceN/A-18.30%2.72%-7.41% Qilian International Holding Group Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BGMQilian International Holding GroupN/A$10.72-1.4%N/AN/A$1.04B$25.10M0.00298PTCTPTC Therapeutics3.7252 of 5 stars$50.96-6.0%$63.77+25.1%+61.1%$4.02B$806.78M-8.581,410Gap DownHigh Trading VolumeZLABZai Lab1.9935 of 5 stars$36.14-3.1%$47.37+31.1%+130.8%$3.96B$398.99M-13.051,950Insider TradeNews CoverageGap DownHigh Trading VolumeOGNOrganon & Co.4.6691 of 5 stars$14.92+2.8%$20.80+39.4%-19.5%$3.85B$6.40B4.4810,000Positive NewsGap DownACLXArcellx1.9307 of 5 stars$65.60-3.5%$108.46+65.3%-1.2%$3.60B$107.94M-92.3980News CoveragePositive NewsGap DownRNAAvidity Biosciences2.4824 of 5 stars$29.52-6.6%$66.69+125.9%+5.5%$3.55B$10.90M-10.25190Insider TradeGap DownHigh Trading VolumeRAREUltragenyx Pharmaceutical4.3065 of 5 stars$36.21-4.3%$92.79+156.2%-25.4%$3.35B$560.23M-5.711,310News CoveragePositive NewsGap DownRYTMRhythm Pharmaceuticals4.3166 of 5 stars$52.97-3.3%$69.46+31.1%+21.8%$3.35B$130.13M-12.23140Gap DownSWTXSpringWorks Therapeutics1.8508 of 5 stars$44.13-6.9%$73.20+65.9%-6.8%$3.31B$191.59M-12.68230AKROAkero Therapeutics4.0381 of 5 stars$40.48-5.2%$76.29+88.5%+72.5%$3.22BN/A-10.7930Gap DownCRNXCrinetics Pharmaceuticals4.2855 of 5 stars$33.54-3.4%$73.00+117.7%-39.4%$3.12B$1.04M-8.99210News CoveragePositive NewsGap DownHigh Trading Volume Remove Ads Related Companies and Tools Related Companies PTCT Competitors ZLAB Competitors OGN Competitors ACLX Competitors RNA Competitors RARE Competitors RYTM Competitors SWTX Competitors AKRO Competitors CRNX Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BGM) was last updated on 4/4/2025 by MarketBeat.com Staff From Our PartnersWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredFeds Just Admitted It—They Can Take Your CashThe Government Just Said Your Money Isn't Yours That's right—According to the DOJ, YOUR hard-earned money i...Priority Gold | SponsoredThree new patents reveal Elon and Trump’s secret “Project America”Right now for a limited time… You can get Tim Bohen’s top 5 Trump stocks for 2025… For only ONE DOLLAR!...Timothy Sykes | SponsoredTrump’s Secret WeaponPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredTrump Makes Major Crypto AnnouncementTrump Ends the “War on Crypto” I expect it to pump the market, which is why I'm recommending ONE coin to al...Crypto 101 Media | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredCaught on Camera: Elon Musk’s “Area 51”You won’t believe what tech legend Jeff Brown found in what he calls Elon Musk’s “Area 51.” (Click here to see...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Qilian International Holding Group Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Qilian International Holding Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy BGM Stock Free BGM Stock Alerts